• Contact quintiles

    Phone:+1 866 267 4479

    Request a Proposal

  • Central Nervous System

  • clinical-trials-header
  • Quintiles Clinical Trial

    Developing products to treat diseases of the central nervous system poses a number of hurdles.

    Recruitment difficulties. Subjective outcome measures. Treatment adherence issues.

    Quintiles can help you navigate the challenges of any CNS study from Alzheimer’s trials to pain studies. So you can reduce costs, accelerate timelines and manage risk.

    Quintiles’ CNS experts and data-driven approach can help you overcome obstacles to your product’s success:

    • Clinical development – Our team leverages expertise in protocol design, biomarker strategies and diagnostic imaging technologies that are opening doors for CNS research
    • Trial operations – Global medical and operational staff accelerate recruitment and streamline trials
    • Outcomes reporting – Trained investigators understand the nuances of subjective outcomes 
    • Commercial strategies – Sales and marketing specialists with neuroscience experience can speed your market entry 

    For your next CNS study, tap into our deep expertise in a wide range of psychological and neurological disorders:

    • ADHD, Bipolar disorders, Multiple Sclerosis, Sleep disorders
    • Addiction disorders, Depression, Pain Stroke
    • Alzheimer’s disease, Epilepsy, Parkinson’s disease
    • Anxiety, Migraine, Schizophrenia

  • Central Nervous System Trials Expertise

  • Quintiles Clinical Trails

    Quintiles can help you navigate every stage of product development to achieve a successful outcome. We meet your needs for broad and deep CNS expertise in each aspect of the process.                             Read fact sheet

  • Quintiles Clinical Trails

    As the global population ages, pharma is racing to develop therapies that will slow or stop progression of Alzheimer's disease. This white paper explores the potential barriers and ways to navigate the hurdles. Read white paper